Cannabis Leader Tilray Sees Boom and Bust, in a Matter of Minutes
*By Kavitha Shastry*
Shares of Canadian cannabis company Tilray were halted throughout the last hour of trading Wednesday after the stock rose more than 90 percent and then sharply pulled back.
The first stoppage occurred just before 3 pm ET after the stock hit $300 a share and then dropped $37 in a matter of minutes. Shares were halted four more times during the last hour of trading and fell as low as $151 ー 2 percent *below* Tuesday's closing price ー before finally ending the day up about 40 percent.
Debra Borchardt, CEO and Editor-in-Chief of marijuana publication Green Market Report, told Cheddar that the volatility was partly driven by short sellers capitalizing on "outsized valuations".
"You can't have one of these charts where the stock is just going straight up without something happening," she said. "If it goes up this hard and fast, it usually comes down very hard and fast. That's why you have the short sellers, and they feel like it's a no-brainer."
The rise of Tilray has certainly been nothing short of spectacular ー the stock debuted on the Nasdaq two months ago at $17 apiece for a market value of about $1.5 billion. At its highs on Wendesday, the company was worth more than $27 billion, eclipsing much more established names like Kellogg, Best Buy, and CBS ー companies that have revenues orders of magnitude more than Tilray.
Investors have been piling into the stock and others in the industry on the heels of a slew of both positive and speculative headlines. Earlier this week Tilray got DEA clearance to import cannabis to the U.S. for a University of California San Diego research study, appears to be paying off. That comes after [reports](https://cheddar.com/videos/coca-cola-to-jump-on-cannabis-train) Coca-Cola was teaming up with Aurora Cannabis to make CBD-infused drinks and an investment by Corona-maker Constellation Brands in [Canopy Growth](https://cheddar.com/videos/corona-brewer-adds-cannabis-to-its-booze-business-in-4-billion-deal).
As a group, marijuana stocks are up about 30 percent since August, [according to IHS Markit](https://www.nytimes.com/2018/09/17/business/dealbook/shorting-cannabis-stocks-costly.html).
But many market watchers expect there to be big swings. On Wednesday morning Citron Research, known for making bearish bets on stocks, [tweeted](https://twitter.com/CitronResearch/status/1042395769372909568) that Tilray's jump was "beyond comprehension." The firm said, "We are short and will hold a manageable position until rationality sets in."
Shares of Tilray were trading down again after hours but were nevertheless still more than ten times their IPO price.
For full interview [click here](https://cheddar.com/videos/inside-tilrays-soaring-market-cap).
Wealthfront’s CFO Alan Iberman talks the $2.05B IPO and the major moment for robo banking as the company bets on AI, automation, and “self-driving money."
A rare magnum of Dom Pérignon Vintage 1961 champagne that was specially produced for the 1981 wedding of Prince Charles and Lady Diana has failed to sell during an auction. Danish auction house Bruun Rasmussen handled the bidding Thursday. The auction's house website lists the bottle as not sold. It was expected to fetch up to around $93,000. It is one of 12 bottles made to celebrate the royal wedding. Little was revealed about the seller. The auction house says the bids did not receive the desired minimum price.
The New York Times and President Donald Trump are fighting again. The news outlet said Wednesday it won't be deterred by Trump's “false and inflammatory language” from writing about the 79-year-old president's health. The Times has done a handful of stories on that topic recently, including an opinion column that said Trump is “starting to give President Joe Biden vibes.” In a Truth Social post, Trump said it might be treasonous for outlets like the Times to do “FAKE” reports about his health and "we should do something about it.” The Republican president already has a pending lawsuit against the newspaper for its past reports on his finances.
OpenAI has appointed Slack CEO Denise Dresser as its first chief of revenue. Dresser will oversee global revenue strategy and help businesses integrate AI into daily operations. OpenAI CEO Sam Altman recently emphasized improving ChatGPT, which now has over 800 million weekly users. Despite its success, OpenAI faces competition from companies like Google and concerns about profitability. The company earns money from premium ChatGPT subscriptions but hasn't ventured into advertising. Altman had recently announced delays in developing new products like AI agents and a personal assistant.
President Donald Trump says he will allow Nvidia to sell its H200 computer chip used in the development of artificial intelligence to “approved customers” in China. Trump said Monday on his social media site that he had informed China’s leader Xi Jinping and “President Xi responded positively!” There had been concerns about allowing advanced computer chips into China as it could help them to compete against the U.S. in building out AI capabilities. But there has also been a desire to develop the AI ecosystem with American companies such as chipmaker Nvidia.
